Engineered triple inhibitory receptor resistance improves anti-tumor CAR-T cell performance via CD56
The inhibitory receptors PD-1, Tim-3 and Lag-3 act as negative feedback regulators of T cell responses. Here the authors improve CAR T cell antitumor efficacy by triple knockdown of these receptors, show it requires CD56, and correlate CD56-mediated homophilic cell interactions with CAR T cell effic...
Guardado en:
Autores principales: | Fan Zou, Lijuan Lu, Jun Liu, Baijin Xia, Wanying Zhang, Qifei Hu, Weiwei Liu, Yiwen Zhang, Yingtong Lin, Shuliang Jing, Mei Huang, Bifen Huang, Bingfeng Liu, Hui Zhang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/62ecd82ea5c54588adc2d3e0f20f49a1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
PECULIARITIES OF NK CELLS DIFFERENTIATION: CD56dim AND CD56bright NK CELLS AT PREGNANCY AND IN NON-PREGNANT STATE
por: V. A. Mikhailova, et al.
Publicado: (2017) -
CAR T-Cell Therapy: Is CD28-CAR Heterodimerization Its Achilles’ Heel?
por: Leonardo M. R. Ferreira, et al.
Publicado: (2021) -
Comprehensive Analyses of Type 1 Diabetes Ketosis- or Ketoacidosis-Related Genes in Activated CD56+CD16+ NK Cells
por: Ruifeng Shi, et al.
Publicado: (2021) -
Directed evolution of an LBP/CD14 inhibitory peptide and its anti-endotoxin activity.
por: Li Fang, et al.
Publicado: (2014) -
CD56 Is a Pathogen Recognition Receptor on Human Natural Killer Cells
por: Sabrina Ziegler, et al.
Publicado: (2017)